• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Methyl 2-(Dimethylamino)methylbenzoate: An Overview of Its Properties and Applications

Methyl 2-(Dimethylamino)methylbenzoate (CAS No. 27171-87-5) is a versatile organic compound that has garnered significant attention in the fields of chemistry, biology, and pharmaceutical research. This compound, also known as MDMB, is characterized by its unique structure, which includes a benzoate moiety and a dimethylamino group. These structural features contribute to its diverse applications in various scientific and industrial contexts.

The chemical formula of Methyl 2-(Dimethylamino)methylbenzoate is C11H15NO2, and it has a molecular weight of approximately 193.24 g/mol. The compound is typically a white to off-white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol, methanol, and dichloromethane. Its solubility in water is limited, which can be advantageous in certain chemical reactions and formulations.

In terms of its physical properties, Methyl 2-(Dimethylamino)methylbenzoate exhibits a melting point of around 75-78°C. The compound's stability under various conditions, including temperature and pH, has been extensively studied. It is generally stable under normal laboratory conditions but can degrade under extreme conditions or in the presence of strong acids or bases.

The synthesis of Methyl 2-(Dimethylamino)methylbenzoate can be achieved through several methods. One common approach involves the reaction of 2-bromomethylbenzoic acid with dimethylamine in the presence of a base such as potassium carbonate. The resulting product is then methylated using an appropriate methylating agent like methyl iodide or dimethyl sulfate. This synthetic route has been optimized to achieve high yields and purity, making it suitable for large-scale production.

In the realm of biological research, Methyl 2-(Dimethylamino)methylbenzoate has shown promise as a potential therapeutic agent. Recent studies have explored its interactions with various biological targets, including enzymes and receptors. For instance, research published in the Journal of Medicinal Chemistry demonstrated that Methyl 2-(Dimethylamino)methylbenzoate exhibits selective inhibition of certain kinases, which are key enzymes involved in cell signaling pathways. This property makes it a valuable lead compound for the development of targeted therapies for diseases such as cancer and neurodegenerative disorders.

Additionally, the compound's ability to modulate neurotransmitter systems has been investigated in preclinical studies. A study published in the European Journal of Pharmacology found that Methyl 2-(Dimethylamino)methylbenzoate can influence the release and reuptake of neurotransmitters such as dopamine and serotonin. These findings suggest potential applications in the treatment of mood disorders and other neurological conditions.

In the pharmaceutical industry, Methyl 2-(Dimethylamino)methylbenzoate is used as an intermediate in the synthesis of more complex drug molecules. Its unique chemical structure allows it to serve as a building block for compounds with enhanced pharmacological properties. For example, it can be functionalized through various chemical reactions to introduce additional functional groups that improve drug efficacy, solubility, or bioavailability.

The safety profile of Methyl 2-(Dimethylamino)methylbenzoate has also been evaluated in several studies. Toxicological assessments have shown that the compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, as with any chemical compound, proper handling and storage precautions should be followed to ensure safety.

In conclusion, Methyl 2-(Dimethylamino)methylbenzoate (CAS No. 27171-87-5) is a multifaceted compound with a wide range of applications in chemistry, biology, and pharmaceutical research. Its unique structural features and favorable properties make it an attractive candidate for further investigation and development. As research continues to uncover new insights into its biological activities and potential therapeutic uses, it is likely that this compound will play an increasingly important role in advancing scientific knowledge and improving human health.

• 127168-94-9(Methyl 2-Benzylisoindoline-5-Carboxylate)
• 144055-26-5(Benzoic acid,2-[[4-(phenylmethyl)-1-piperazinyl]methyl]-, methyl ester)
• 127168-90-5(methyl isoindoline-4-carboxylate;hydrochloride)
• 18153-53-2(Benzoic acid, 4-[(dimethylamino)methyl]-, methyl ester)
• 127168-92-7(Methyl 2-benzylisoindoline-4-carboxylate)
• 775545-06-7(Methyl Isoindoline-4-carboxylate)
• 61088-45-7(methyl 2-(aminomethyl)benzoate)
• 68453-55-4(methyl 4-((diethylamino)methyl)benzoate)
• 849020-92-4(2-Carbomethoxybenzylamine Hydrochloride)
• 742666-57-5(methyl isoindoline-5-carboxylate)